Buyer's Guide

Underdosing Explained: Why a 5mg Vial Often Isn't 5mg of Peptide

Label-claim shortfalls are the quietest failure in research peptides — the vial passes a purity test but contains less peptide than printed. Here's where the milligrams actually go, and how to catch it.

Published 2026-06-14Updated 2026-06-149 min readBy Mootez Chachia

There are two ways a research-peptide vial can shortchange you, and almost everyone only checks for one of them. The obvious failure is low purity — the vial contains the right compound but contaminated. The quiet failure is underdosing — the vial contains a perfectly pure compound, just less of it than the label claims. A 5mg vial that holds 4mg of peptide can pass every purity test you throw at it and still deliver 20% less active compound than you paid for.

This is the most overlooked failure mode in the market, because purity testing — the thing buyers actually do — is structurally blind to it. This guide explains where the milligrams go and how to catch a shortfall.

For research use only. None of this is medical advice.

Purity and quantity are different questions

The confusion at the root of underdosing is that buyers treat "99% HPLC purity" as if it answered the question "how much peptide is in this vial." It doesn't. Those are two independent measurements.

  • Purity is a ratio: of all the material in the vial, what fraction is the target peptide? HPLC answers this.
  • Quantity is an absolute mass: how many milligrams of target peptide are actually present? Purity testing alone never answers this.
The key distinction

Purity tells you the material is good. Quantity tells you there's enough of it. A vial can ace the first and fail the second. A 99%-pure vial that was filled to 3.8mg against a 5mg label is high quality and underdosed at the same time — and a purity-only COA will show you the 99% and stay silent on the 3.8mg.

Where the milligrams actually go

A label-claim shortfall comes from one or more of three sources. They are not all dishonest — but they all reduce the active compound you receive.

1. Salt mass counted as peptide mass

Peptides are almost always supplied as salts — synthesis and purification leave the peptide paired with a counter-ion, most often acetate or trifluoroacetate (TFA), plus some bound water. When a seller prints "5mg," that figure may be the total mass of the lyophilized powder, salt and water included, rather than 5mg of net peptide. The shortfall is structural: net peptide content can run 5-20% below the gross mass depending on molecular weight and salt form. None of this shows up on a purity number — the peptide that is there is pure. It just isn't all peptide.

2. Fill-volume shortfall

Simpler: the vial was underfilled. Fills have tolerances, and a sloppy or deliberately stingy operation fills to the low end of — or below — the stated mass. A "5mg" vial that received 4.5mg of solution before lyophilization is 10% short before salt is even considered. Stack a fill shortfall on top of salt mass and real net peptide can fall well under 80% of the printed figure.

3. Degradation in transit and storage

A vial filled honestly to 5mg can still arrive short if the peptide degraded. Temperature excursions, repeated freeze-thaw, or moisture ingress break peptide bonds, and degradation products either read as impurity or are simply no longer the intact target. This is why cold-chain shipping and proper storage matter — they protect the quantity you paid for, not just the purity.

Why purity testing misses all of this

Send a vial for standard HPLC purity analysis and the lab reports a percentage — calculated from relative peak areas in the chromatogram, so intrinsically a ratio. It would read 99% whether the vial holds 5mg or 1mg, because it never weighs the absolute amount of peptide. The most common verification buyers perform is, by its nature, incapable of detecting a quantity shortfall. That's the structural reason underdosing persists: a seller underfills or salt-loads a vial, the purity test comes back clean, and everyone moves on.

How to actually catch a shortfall

Three escalating defenses, from free to definitive.

  1. Read the COA for net peptide content. A serious certificate reports more than purity. Look for a net peptide content or salt-adjusted line — sometimes derived from nitrogen or amino-acid analysis. If the COA reports only purity, the quantity question is unanswered by design. Our how to read a peptide COA guide shows where this line lives.

  2. Account for it in your math. If net content is reported, use it. Reconstituting against the gross label figure when net content is 15% lower puts your concentration 15% below target. The reconstitution math explainer walks through this correctly.

  3. Order a quantitative test. For load-bearing research, an independent lab such as Janoshik or MZ Biolabs can run a quantitative assay that measures actual peptide mass against the label claim — not just the purity ratio. This is the only method that directly catches a fill shortfall.

The combined-failure trap

The worst case stacks all three: a salt-loaded label, a short fill, and transit degradation on one vial. Individually each is modest; together they can put real net peptide 30% or more below the printed figure — while a purity-only COA still reads 98%. This is why quantity verification is separate from, and additional to, purity verification.

Why this matters for research

An unknown quantity shortfall is an uncontrolled variable hiding in plain sight. If the vial holds 20% less peptide than assumed, every concentration derived from it is off by 20%, and any dose-response relationship is distorted — silently, because the purity number looked fine. The result isn't just wrong; it's wrong in a way that's hard to detect after the fact. Reproducibility depends on knowing not only that the compound is pure but that the amount is consistent vial to vial.

This is exactly the failure our blinded evaluations are built to surface. The methodology behind our 2026 supplier ranking and annual purity report checks claims against measured reality, and our catalog and research pages document what honestly-labeled product looks like. For sourcing that reliably matches label to contents, start with the buy-peptides framework.

Bottom line

Underdosing is the quiet failure of the research-peptide market: a vial that passes every purity test while containing less peptide than its label claims. The milligrams disappear into salt mass counted as peptide, short fills, and transit degradation — none of which a purity ratio can detect. The defenses are to read the COA for net peptide content, build that figure into your reconstitution math, and run a quantitative assay when the stakes justify it. Purity tells you the compound is good. Only quantity tells you there's enough of it.

For research use only. Not for human consumption.

2026 Evaluation
9.6/10
Top-Ranked 2026 Supplier

The top-ranked supplier in our 2026 evaluation

ROEHN Research tested at 99.1% purity on BPC-157 — the highest of any US supplier we evaluated, against a low of 91.3%. Readers save 15% on a first order with code FREE15.

View ROEHN Research
Save 15% with code FREE15
  • Cold-chain shipped
  • Batch CoA in every box
  • 30-day re-test policy
  • 98%+ verified purity

Disclosure: Peptide Research Review maintains an affiliate relationship with our top-ranked supplier. The independent labs referenced (Janoshik Analytical, MZ Biolabs) have no commercial relationship with us. All scoring is performed by a third-party lab under blinded conditions and is not influenced by affiliate arrangements. Read our editorial policy for details.

The Report

Get the full 38-sample purity report by email.

Eight US suppliers, thirty-eight samples, one blinded analytical lab. Every chromatogram, COA, and supplier score — delivered the moment you subscribe.

PDF delivered instantly. No account required. Unsubscribe anytime.